|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61P 35/00 | (2006.01) |
| A61K 39/3955 | (2013.01) | ||
| C07K 16/24 | (2006.01) | ||
| A61K 31/00 | (2013.01) | ||
| A61K 31/00 | (2006.01) | ||
| A61K 35/17 | (2013.01) | ||
| A61K 35/17 | (2015.01) | ||
| C07K 16/248 | (2013.01) | ||
| C07K 14/00 | (2006.01) | ||
| C07K 14/00 | (2013.01) | ||
| C12N 15/113 | (2010.01) | ||
| C12N 15/113 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K2317/70 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Patento numeris | 3551294 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17825416.5 |
| Europos patento paraiškos padavimo data | 2017-12-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-10-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-02-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2017/082234 |
| Data | 2017-12-11 |
| (87) | Numeris | WO 2018/104554 |
| Data | 2018-06-14 |
| (30) | Numeris | Data | Šalis |
| 201662432334 P | 2016-12-09 | US | |
| 17179414 | 2017-07-03 | EP |
| (72) |
O'DWYER, Michael Eamon Peter , IE
HU, Jinsong , CN
|
| (73) |
ONK Therapeutics Limited ,
C/O Coll & Company
Pier Road
Barna Village, Co. Galway H91 V6KV,
IE
|
| (54) | IMPROVED NK-BASED CELL THERAPY |
| IMPROVED NK-BASED CELL THERAPY |